Department of Joint Surgery and Sports Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Investigation performed at Tokyo Medical and Dental University, Tokyo, Japan.
Am J Sports Med. 2024 Jun;52(7):1784-1793. doi: 10.1177/03635465241247843. Epub 2024 May 9.
The vancomycin presoaking technique (wherein grafts are treated with a vancomycin solution [VS] for anterior cruciate ligament reconstruction [ACLR]) reduces the infection rate after ACLR. However, the effects of this technique on graft-bone healing have not been fully elucidated.
To investigate the effects of vancomycin presoaking on graft-bone healing in a rat ACLR model.
Controlled laboratory study.
Long flexor digitorum longus tendons were obtained from 9 Wistar rats, and each was randomly allocated to the normal saline (NS) or VS groups. The grafts were immersed in sterile saline for 30 minutes in the NS group and in a 5-mg/mL VS in the VS group. The presence of time-zero graft bacterial contamination was confirmed, and the grafts were incubated in Fluidised Thioglycollate Broth for 2 weeks. ACLR was performed on the right knees of 65 male Wistar rats using the flexor digitorum longus tendons. Each graft was similarly treated. Biomechanical testing, micro-computed tomography, and histological evaluations were performed 4 and 12 weeks postoperatively.
The VS group showed significantly reduced graft contamination at time zero ( = .02). The mean maximum loads to failure were 13.7 ± 8.2 N and 11.6 ± 4.8 N in the NS and VS groups, respectively, at 4 weeks ( = .95); and 23.2 ± 13.2 N and 30.4 ± 18.0 N in the NS and VS groups, respectively, at 12 weeks ( = .35). Regarding micro-computed tomography, the mean bone tunnel volumes were 3.76 ± 0.48 mm and 4.40 ± 0.58 mm in the NS and VS groups, respectively, at 4 weeks ( = .41); and 3.51 ± 0.38 mm and 3.67 ± 0.35 mm in the NS and VS groups, respectively, at 12 weeks ( = .54). Histological semiquantitative examination revealed no clear between-group differences at any time point.
Presoaking grafts in vancomycin in a rat ACLR model demonstrated no discernible adverse effects on short- and midterm biomechanical, radiological, and histological investigations.
The findings provide guidance for surgeons when considering this technique.
万古霉素浸泡技术(即将移植物用万古霉素溶液[VS]处理)可降低前交叉韧带重建(ACLR)后的感染率。然而,该技术对移植物-骨愈合的影响尚未完全阐明。
研究万古霉素浸泡对大鼠 ACLR 模型中移植物-骨愈合的影响。
对照实验室研究。
从 9 只 Wistar 大鼠中获得长屈肌腱,并将其随机分配到生理盐水(NS)或 VS 组。在 NS 组中,将移植物浸泡在无菌盐水中 30 分钟,而在 VS 组中浸泡在 5mg/mL 的 VS 中。确认零时间移植物细菌污染的存在,并用流化硫代甘氨酸肉汤孵育 2 周。使用长屈肌腱对 65 只雄性 Wistar 大鼠的右膝关节进行 ACLR。每个移植物都进行了类似的处理。术后 4 周和 12 周分别进行生物力学测试、微计算机断层扫描和组织学评估。
VS 组在零时的移植物污染明显减少( =.02)。NS 组和 VS 组的最大失效载荷分别为 4 周时的 13.7 ± 8.2N 和 11.6 ± 4.8N( =.95);以及 12 周时的 23.2 ± 13.2N 和 30.4 ± 18.0N( =.35)。关于微计算机断层扫描,NS 组和 VS 组的平均骨隧道体积分别为 4 周时的 3.76 ± 0.48mm 和 4.40 ± 0.58mm( =.41);以及 12 周时的 3.51 ± 0.38mm 和 3.67 ± 0.35mm( =.54)。组织学半定量检查在任何时间点均未显示出组间差异。
在大鼠 ACLR 模型中,将移植物浸泡在万古霉素中未见对短期和中期生物力学、影像学和组织学研究有明显的不良影响。
该研究结果为外科医生考虑该技术提供了指导。